Seoul, South Korea

Don-Gil Lee

This inventor holds 1 USPTO granted patent. Top assignee: Ildong Pharmaceutical Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Don-Gil Lee. Retrieved from https://idiyas.com/inventor/don-gil-lee-qgrnm4n9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Don-Gil Lee: Inventor in Seoul

Introduction

Don-Gil Lee is an inventor based in Seoul, South Korea. His patent work includes research on a *Bifidobacterium breve* strain and its potential applications related to dyslipidemia.

Latest Patents

Lee is associated with 1 patent: “Novel *Bifidobacterium breve* IDCC 4401 Strain and Its Dead Cell ID-BBR4401 Having Excellent Acid Tolerance and Bile Tolerance and Prophylactic or Therapeutic Effect on Dyslipidemia.” The invention concerns a bacterial strain and its dead-cell form, with described acid and bile tolerance and potential prophylactic or therapeutic effects on dyslipidemia.

Career Highlights

Lee’s listed patent is associated with Ildong Pharmaceutical Co., Ltd. It focuses on a probiotic-related invention and its potential health applications.

Collaborations

Lee’s listed coworkers include Min-Goo Kim and Tae-Yoon Kim.

Conclusion

Don-Gil Lee’s patent record highlights work on a *Bifidobacterium breve* strain and its potential role in addressing dyslipidemia.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…